Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
George Jay Goldsmith | Director | 2024-03-13 | 17,203 | $10.81 | $185.88kSell |
George Jay Goldsmith | Director | 2024-03-13 | 17,203 | $10.81 | $185.88kSell |
Ekaterina Malievskaia | Director | 2024-03-13 | 17,203 | $10.81 | $185.88kSell |
Ekaterina Malievskaia | Director | 2024-03-13 | 17,203 | $10.81 | $185.88kSell |
Ekaterina Malievskaia | Director | 2024-03-12 | 15,740 | $10.58 | $166.53kSell |
George Jay Goldsmith | Director | 2024-03-12 | 15,740 | $10.58 | $166.53kSell |
George Jay Goldsmith | Director | 2024-03-12 | 15,740 | $10.58 | $166.53kSell |
Ekaterina Malievskaia | Director | 2024-03-12 | 15,740 | $10.58 | $166.53kSell |
George Jay Goldsmith | Director | 2024-02-26 | 17,765 | $10.45 | $185.61kSell |
Ekaterina Malievskaia | Director | 2024-02-26 | 17,765 | $10.45 | $185.61kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ekaterina Malievskaia | 19.32% | 12,405,735 | $115.50M | Insider |
George Jay Goldsmith | 19.29% | 12,389,731 | $115.35M | Insider |
Life Sciences Nv Atai | 14.89% | 9,565,774 | $89.06M | Insider |
Tcg Crossover Management LLC | 6.01% | 3,858,000 | $35.92M | Institution |
Ark Investment Management LLC | 4.08% | 2,618,871 | $24.38M | Institution |
Paradigm Biocapital Advisors LP | 3.53% | 2,265,988 | $21.10M | Institution |
Vivo Capital LLC | 2.50% | 1,608,000 | $14.97M | Institution |
Citadel Advisors LLC | 2.44% | 1,565,000 | $14.57M | Institution |
Ra Capital Management LP | 2.00% | 1,286,000 | $11.97M | Institution |
Soleus Capital Management LP | 1.50% | 964,550 | $8.98M | Institution |